Phaseline

Targets › RPOBC

RPOBC: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 3; Infectious disease.

Open in Phaseline: the race on RPOBC, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
ANRS, Emerging Infectious DiseasesLinezolid
Bacterial 70S ribosome inhibitor
RPOBCPhase 3Tuberculous Meningitis–

Conditions

Tuberculous Meningitis (1)

Modalities

small molecule (1)

Companies

ANRS, Emerging Infectious Diseases (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.